At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions.
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: rare bleeding disorders, growth hormone related disorders and obesity.
Headquartered in Denmark, Novo Nordisk employs approximately 42,700 people in 79 countries and markets its products in more than 170 countries.
Novo Nordisk discovers and develops innovative medicines and makes them accessible to patients throughout the world. Nearly a century of innovation and leadership has led to the development of a comprehensive portfolio of products and delivery systems for diabetes care, as well as in other therapeutic areas where the company can make a difference.